2468 related articles for article (PubMed ID: 19736473)
41. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Woolf K; Manore MM
J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
[TBL] [Abstract][Full Text] [Related]
42. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
43. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
44. The C677T thermolabile variant of methylene tetrahydrofolate reductase on homocysteine, folate and vitamin B12 in a hemodialysis center.
Trimarchi H; Genoud V; Schiel A; Castañon M; Freixas E; Diaz ML; Schropp J; Martino D; Pereyra H; Kordich L
Medicina (B Aires); 2002; 62(2):149-53. PubMed ID: 12038037
[TBL] [Abstract][Full Text] [Related]
45. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
[TBL] [Abstract][Full Text] [Related]
46. [Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients].
Corghi E; Patrosso C; Bamonti F; Baragetti I; Novembrino C; Lando G; De Franceschi M; Buccianti G
G Ital Nefrol; 2002; 19(3):301-7. PubMed ID: 12195398
[TBL] [Abstract][Full Text] [Related]
47. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
[TBL] [Abstract][Full Text] [Related]
48. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.
Holm PI; Bleie Ø; Ueland PM; Lien EA; Refsum H; Nordrehaug JE; Nygård O
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):301-7. PubMed ID: 14699020
[TBL] [Abstract][Full Text] [Related]
49. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
Alvares Delfino VD; de Andrade Vianna AC; Mocelin AJ; Barbosa DS; Mise RA; Matsuo T
Nutrition; 2007 Mar; 23(3):242-7. PubMed ID: 17321110
[TBL] [Abstract][Full Text] [Related]
50. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
51. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
[TBL] [Abstract][Full Text] [Related]
52. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Yango A; Shemin D; Hsu N; Jacques PF; Dworkin L; Selhub J; Bostom AG
Kidney Int; 2001 Jan; 59(1):324-7. PubMed ID: 11135086
[TBL] [Abstract][Full Text] [Related]
53. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
54. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
55. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
56. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation.
Koyama K; Usami T; Takeuchi O; Morozumi K; Kimura G
Nephrol Dial Transplant; 2002 May; 17(5):916-22. PubMed ID: 11981084
[TBL] [Abstract][Full Text] [Related]
58. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses.
Ipcioglu OM; Ozcan O; Gultepe M; Ates A; Basoglu C; Cakir E
Clin Biochem; 2008 Jul; 41(10-11):831-5. PubMed ID: 18457673
[TBL] [Abstract][Full Text] [Related]
59. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke.
Ullegaddi R; Powers HJ; Gariballa SE
Clin Sci (Lond); 2004 Nov; 107(5):477-84. PubMed ID: 15279619
[TBL] [Abstract][Full Text] [Related]
60. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
